[go: up one dir, main page]

AU9276398A - Materials and methods relating to the stimulation of cells - Google Patents

Materials and methods relating to the stimulation of cells

Info

Publication number
AU9276398A
AU9276398A AU92763/98A AU9276398A AU9276398A AU 9276398 A AU9276398 A AU 9276398A AU 92763/98 A AU92763/98 A AU 92763/98A AU 9276398 A AU9276398 A AU 9276398A AU 9276398 A AU9276398 A AU 9276398A
Authority
AU
Australia
Prior art keywords
stimulation
cells
materials
methods relating
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU92763/98A
Inventor
David Darling
Farzin Farzaneh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of AU9276398A publication Critical patent/AU9276398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/428—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/625—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier binding through the biotin-streptavidin system or similar

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU92763/98A 1997-10-03 1998-10-05 Materials and methods relating to the stimulation of cells Abandoned AU9276398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9721075 1997-10-03
GBGB9721075.1A GB9721075D0 (en) 1997-10-03 1997-10-03 Materials and methods relating to the stimulation of cells
PCT/GB1998/002978 WO1999017801A2 (en) 1997-10-03 1998-10-05 Materials and methods relating to the stimulation of cells

Publications (1)

Publication Number Publication Date
AU9276398A true AU9276398A (en) 1999-04-27

Family

ID=10820052

Family Applications (1)

Application Number Title Priority Date Filing Date
AU92763/98A Abandoned AU9276398A (en) 1997-10-03 1998-10-05 Materials and methods relating to the stimulation of cells

Country Status (3)

Country Link
AU (1) AU9276398A (en)
GB (1) GB9721075D0 (en)
WO (1) WO1999017801A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6775320B1 (en) 1999-03-12 2004-08-10 Aware, Inc. Method and a multi-carrier transceiver supporting dynamic switching between active application sets
US7927602B2 (en) 2002-07-23 2011-04-19 University Of Louisville Research Foundation, Inc. Fas ligand-avidin/streptavidin fusion proteins
JP4898049B2 (en) * 2000-01-24 2012-03-14 ユニバーシティ オブ ルイビル リサーチ ファウンデーション，インコーポレイティド Immune regulation by death receptor-induced apoptosis
ATE531789T1 (en) * 2000-06-30 2011-11-15 Univ Louisville Res Found CELL MEMBRANE CHANGES
JP7462578B2 (en) * 2018-03-15 2024-04-05 ファンダメンタル ソリューションズ コーポレーション Programmable immune cell receptor complex system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19633731A1 (en) * 1996-08-21 1998-02-26 Johann Hinrich Prof Dr Peters Hybrid cells used as anti-cancer vaccine

Also Published As

Publication number Publication date
GB9721075D0 (en) 1997-12-03
WO1999017801A3 (en) 1999-06-17
WO1999017801A2 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
AU6763898A (en) Gel sensors and methods of use thereof
AU7710198A (en) Single pass lead and method of use
AU7612196A (en) Functional human hematopoietic cells
AU3821689A (en) Enzyme electrodes and improvements in the manufacture thereof
AU7362998A (en) Solid state electrochemical sensors and methods of making the same
AU8849098A (en) Baculovirus artificial chromosomes and methods of use
AU5482599A (en) Human mesencephalon cell lines and methods of use therefor
AU4636699A (en) Materials and methods relating to encapsulation
AU6855796A (en) In vivo electroporation of cells
AU6695398A (en) Immunoadhesins and methods of production and use thereof
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU2327095A (en) Improvements in and relating to the reclaimimg of elastomeric materials
AU4524899A (en) Materials and methods relating to the induction of apoptosis in target cells
AU2418499A (en) Org-5222 in the treatment of depression
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU8582298A (en) Methods of forming battery electrodes
AU2682895A (en) EG Cells of Ungulates
AU2087799A (en) Diagnostic and therapeutic methods based upon valpha24jalphaq t cells
AU1220599A (en) Method for the production and use of dendritic cells
AU9276398A (en) Materials and methods relating to the stimulation of cells
AU2197999A (en) Method for facilitating the introduction of material into cells or structures
AU6762800A (en) Methods and materials relating to cd39-like polypeptides
AU4629596A (en) Materials and methods relating to the regulation of polypeptide production in cells
AU7137996A (en) Materials and methods relating to the transfer of nucleic acid into quiescent cells
AU5779798A (en) Culture unit and method of manufacturing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase